View on Pubmed.gov 32851028 | View on doi.org 10.3389/fvets.2...
Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against .
- College of Animal Science and Veterinary Medicine of Henan Institute of Science and Technology, Xinxiang, China. Guangdong Provincial Key Laboratory of Veterinary Drugs Development and Safety Evaluation, South China Agricultural University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Veterinary Drugs Development and Safety Evaluation, South China Agricultural University, Guangzhou, China.
Abstract
This study aimed to explore the application of microdialysis in pharmacokinetic (PK)/pharmacodynamic (PD) integration of cefquinome against . After the population reached 10 CFU/thigh, the mice received 0.04, 0.16, 0.63, 2.5, and 10 mg/kg cefquinome by subcutaneous injection. Plasma samples were collected by retro-orbital puncture for 4 h, and thigh dialysate was obtained by microdialysis at a flow rate of 1.5 μL/min for 6 h for the PK study. For the PD experiment, the infected mice were treated with a 4-fold-increase in the total cefquinome dose, ranging from 0.01 to 10 mg/kg/24 h, divided into one, two, three, four, and eight doses. The number of bacteria was determined and an inhibitory sigmoid maximum effect (E) model was used to analyse the relationships between PK/PD parameters and efficacy. The mean penetration of cefquinome from plasma to the thigh was 0.591. The PK data for PK/PD integration were obtained by extrapolation. The fittest PK/PD parameter for efficacy evaluation was %T>MIC (the percentage of time that free drug concentrations exceed the MIC). The magnitudes of %T>MIC to achieve net bacterial stasis, 1-log CFU reduction, 2-log CFU reduction, and 3-log CFU reduction were 19.56, 28.65, 41.59, and 67.07 % in plasma and 21.74, 36.11, 52.96, and 82.68% in murine thigh, respectively. Microdialysis was first applied to evaluate the PK/PD integration of cefquinome against . These results would provide valuable references when we apply microdialysis to study the PK/PD integration model and use cefquinome to treat animal diseases caused by .
References
J Infect Dis. 2006 Dec 1;194(11):1601-8
Vet Microbiol. 2011 May 12;150(1-2):203-6
BMC Vet Res. 2015 Jul 25;11:169
Antimicrob Agents Chemother. 2015 Dec 14;60(2):1114-20
Cited by 7 citations (total)
Journal Article
Disposition of Cefquinome in Turkeys () Following Intravenous and Intramuscular Administration.
Electronic publication date November 28, 2021
Mohamed Elbadawy [...] Mohamed Aboubakr et al.
The bioavailability and pharmacokinetics in turkeys of cefquinome (CFQ), a broad-spectrum 4th-generation cephalosporin antibiotic, were explored after a single injection...
Journal Article
Pharmacokinetic/Pharmacodynamic Relationships of Tulathromycin Against in a Porcine Tissue Cage Infection Model.
Electronic publication date April 15, 2022
Lihua Yao [...] Huanzhong Ding et al.
Tulathromycin is a semi-synthetic macrolide antibiotic that is highly effective in treating respiratory tract bacterial infections. We evaluated the ...
Conflict of interest statement
MeSH
- •
Specialties
- •
- •
- •
- •
Copyright
Copyright © 2020 Zhang, Zhou, Gu, Huang, Shen and Ding.